|
ADT
ADT Inc.
ADT · Q2 FY2023
|
Q2 FY2023 |
|
ADT Q2 FY2023 transcript
|
|
GWH
ESS Tech, Inc.
GWH · Q2 FY2023
|
Q2 FY2023 |
|
GWH Q2 FY2023 transcript
|
|
TECH
BIO-TECHNE Corp
TECH · Q4 FY2023
|
Q4 FY2023 |
|
TECH Q4 FY2023 transcript
|
|
DAR
Darling Ingredients Inc.
DAR · Q2 FY2024
|
Q2 FY2024 |
|
DAR Q2 FY2024 transcript
|
|
PLTK
Playtika Holding Corp.
PLTK · Q2 FY2023
|
Q2 FY2023 |
|
PLTK Q2 FY2023 transcript
|
|
QMCO
Quantum Corp /De/
QMCO · Q1 FY2024
|
Q1 FY2024 |
|
QMCO Q1 FY2024 transcript
|
|
HAE
Haemonetics Corp
HAE · Q1 FY2024
|
Q1 FY2024 |
|
HAE Q1 FY2024 transcript
|
|
LLY
ELI LILLY & Co
LLY · Q2 FY2023
|
Q2 FY2023 |
|
LLY Q2 FY2023 transcript
|
|
PNTG
Pennant Group, Inc.
PNTG · Q2 FY2023
|
Q2 FY2023 |
|
PNTG Q2 FY2023 transcript
|
|
CGTX
Cognition Therapeutics Inc
CGTX · Q2 FY2023
|
Q2 FY2023 |
|
CGTX Q2 FY2023 transcript
|
|
WGS
GeneDx Holdings Corp.
WGS · Q2 FY2023
|
Q2 FY2023 |
|
WGS Q2 FY2023 transcript
|
|
SND
Smart Sand, Inc.
SND · Q2 FY2023
|
Q2 FY2023 |
|
SND Q2 FY2023 transcript
|
|
MAC
Macerich Co
MAC · Q2 FY2023
|
Q2 FY2023 |
|
MAC Q2 FY2023 transcript
|
|
BARK
Bark, Inc.
BARK · Q1 FY2024
|
Q1 FY2024 |
|
BARK Q1 FY2024 transcript
|
|
MCRB
Seres Therapeutics, Inc.
MCRB · Q2 FY2023
|
Q2 FY2023 |
|
MCRB Q2 FY2023 transcript
|
|
GBLI
Global Indemnity Group, LLC
GBLI · Q2 FY2023
|
Q2 FY2023 |
|
GBLI Q2 FY2023 transcript
|
|
AIRI
Air Industries Group
AIRI · Q2 FY2023
|
Q2 FY2023 |
|
AIRI Q2 FY2023 transcript
|
|
AMC
Amc Entertainment Holdings, Inc.
AMC · Q2 FY2023
|
Q2 FY2023 |
|
AMC Q2 FY2023 transcript
|
|
HBIO
Harvard Bioscience Inc
HBIO · Q2 FY2023
|
Q2 FY2023 |
|
HBIO Q2 FY2023 transcript
|
|
PRKS
United Parks & Resorts Inc.
PRKS · Q2 FY2023
|
Q2 FY2023 |
|
PRKS Q2 FY2023 transcript
|
|
URG
Ur-Energy Inc
URG · Q2 FY2023
|
Q2 FY2023 |
|
URG Q2 FY2023 transcript
|
|
ESE
Esco Technologies Inc
ESE · Q3 FY2023
|
Q3 FY2023 |
|
ESE Q3 FY2023 transcript
|
|
LAB
Standard Biotools Inc.
LAB · Q2 FY2023
|
Q2 FY2023 |
|
LAB Q2 FY2023 transcript
|
|
PCT
PureCycle Technologies, Inc.
PCT · Q2 FY2023
|
Q2 FY2023 |
|
PCT Q2 FY2023 transcript
|